Seven Million Vaccine Doses Remain in Stock

Following the conclusion of the COVID-19 pandemic, a significant stockpile of vaccines remains available in Germany. Currently, the federal government has seven million doses stored in its central warehouse, as confirmed by the Health Ministry in Berlin.

The government has ceased purchasing additional vaccines. However, due to obligations arising from participation in a vaccine initiative led by the European Commission, there are still commitments to procure products from manufacturers BioNTech and Novavax.

The Health Ministry clarified that COVID-19 vaccines from these companies will continue to be provided at no cost until at least 2026. The once overwhelming demand for COVID-19 vaccinations has notably diminished over time. This decline follows the onset of the crisis five years ago, marked by the first lockdown in Germany, which imposed nationwide closures and contact restrictions.

As the pandemic unfolded, the virus SARS-CoV-2 dramatically altered daily life and challenged the scientific community to respond rapidly. Since late 2019, researchers have been working diligently to develop tests and vaccines, including those for children, adapting to the evolving situation.

The ongoing management of COVID-19 continues to evolve as vaccination rates stabilize, and public health measures adapt to new variants of the virus. Authorities remain committed to ensuring that the existing vaccine supply is utilized effectively while preparing for any future health emergencies.